GlaxoSmithKline Articles
Indian patent law changes will benefit Pharma multinationals
19 August 2009
Zacks analysts view AstraZeneca/Forest deal favorably
18 August 2009
Patent protection for key blockbuster depression drugs will drive growth in Europe and Japan, but not USA, says DR report
18 August 2009
Vectura $6m milestone payment for VR315 from Novartis
13 August 2009
US FDA approves Ranbaxy’s generic sumatriptan
11 August 2009
Aileron closes $40M financing
9 June 2009
GSK's malaria vacc enters Ph III testing
5 June 2009
Adolor cuts back to focus on Entereg
5 June 2009
FDA eyes orlistat for potential liver problems, Chantix under scrutiny for skin reaction
5 June 2009
Stock Commentary - Europe - week to June 1, 2009
4 June 2009
Merieux planning to sell Shantha Biotech
3 June 2009
Affiris gets grant for cholesterol vaccine
1 June 2009
Dr Reddy's falls to loss on goodwill adjustment
1 June 2009
Teva launches YouTube channel for PD
29 May 2009
Australian govt stockpiles additional Relenza
29 May 2009
Retail drug sales in year to March 2009
22 May 2009
Stock Commentary - Europe - week to May 18, 2009
21 May 2009
BMJ: lymphatic filiarisis could be on way out
21 May 2009
BMJ: lymphatic filiarisis could be on way out
15 May 2009
Deal secured for pre-pandemic vaccine for UK
15 May 2009
GSK expands into Africa with 16% stake in Aspen
13 May 2009
UPDATE: Ligand's 1st-qtr 2009 loss deepens 30%
12 May 2009
Neurocrine cuts loss despite 59% sales drop
8 May 2009
Ligand narrows loss on rocketing revenue
8 May 2009
Simcere seeking appro for generic zanamavir
7 May 2009
Pozen cuts loss 53%, attracts Zacks interest
6 May 2009
GSK sells US Wellbutrin rights for $510M
6 May 2009
Celgene swings back to profit in 1st qtr
5 May 2009
EMEA prepares for pandemic vaccines
1 May 2009
Shire sales up 20% pre-Adderall demise
1 May 2009
UK gets warning on counterfeit swine flu drugs
30 April 2009
EVM meets EC and EMEA over swine flu
30 April 2009
Stock Commentary - Europe - week to April 27, 2009
30 April 2009
UK pharmacists alerted on orlistat dispensing
28 April 2009
GSK/Xenoport drug fails Ph II DPN study
28 April 2009
"No evidence" of risk with abacavir; CHMP
27 April 2009
URCH study foresees more pharma mega-mergers
27 April 2009
GSK's Avamys launched in UK
27 April 2009
Retail drug sales in year to February 2009
24 April 2009
Almirall names Steve Webber as senior discovery director
23 April 2009
Stock Commentary - Europe - week to April 20, 2009
23 April 2009
GSK France welcomes alli launch OK from EC
22 April 2009
GSK to buy US derma co Steifel for $2.9B+
20 April 2009
GSK and Pfizer pool HIV/AIDS assets in JV
16 April 2009
Sen Grassley probes mental health group
16 April 2009
Stock Commentary - Europe - week to April 13, 2009
16 April 2009
Strativa submits NDA for generic Zofran ODT
15 April 2009
SCLC drug market wil more than double to $648M in 2017
14 April 2009
SAP potential new drug target for Alzheimer's
14 April 2009
DDMAC hits sponsored Internet drug links
14 April 2009
AstraZeneca OTC sale to GSK cleared in Sweden
8 April 2009
Stock Commentary - Europe - week to Aug 15
8 April 2009
Effects of drug donations in kind debated
7 April 2009
Belgium's govt R&D summit convened
3 April 2009
Retail drug sales in year to January 2009
3 April 2009
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
